Dynasty Gene is a Developer of synthetic biology technology and provider of biotechnology consulting services.
Developer of synthetic biology technology and provider of biotechnology consulting services. The company focuses on technology development, technology consulting, technology transfer, and technical services in the biotechnology field, enabling their clients to make advancement in the field of next-generation DNA sequencing (NGS). The company has its own independent intellectual property rights on their Micropore high-throughput DNA synthesis platform, allowing the company to launch a series of products including: liquid biopsy solutions, NGS library capture kits, etc.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 28, 2021 | Series Unknown | — | 1 | ByteDance | — | Detail |
Jun 5, 2021 | Series A | ¥100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ByteDance | Yes | Series Unknown |
Chaosheng Capital | — | Series A |